Design, synthesis and biological activity of 3-oxoamino-benzenesulfonamides as selective and reversible LSD1 inhibitors
- 1 June 2017
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 72, 182-189
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20161458)
- Open Project Program of Jiangsu Key Laboratory of Drug Screening (JKLDS2015KF-03)
- Natural Science Foundation of China (91419306)
This publication has 38 references indexed in Scilit:
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1Cancer Cell, 2011
- Targeting Histone Demethylases: A New Avenue for the Fight against CancerGenes & Cancer, 2011
- Cancer epigenetics: linking basic biology to clinical medicineCell Research, 2011
- Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biologyCarcinogenesis, 2009
- Identification of Cell-Active Lysine Specific Demethylase 1-Selective InhibitorsJournal of the American Chemical Society, 2009
- The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylationNature Genetics, 2008
- LSD1: oxidative chemistry for multifaceted functions in chromatin regulationTrends in Biochemical Sciences, 2008
- Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive MedicationsChemistry & Biology, 2006
- Histone demethylation catalysed by LSD1 is a flavin‐dependent oxidative processFEBS Letters, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004